Clinical development of a once-daily gastroretentive formulation of gabapentin for treatment of postherpetic neuralgia: an overview

Use of opioid analgesics in patients with postherpetic neuralgia (PHN) first treated with gabapentin or pregabalin

(2012) P. Johnson et al.   JOURNAL OF PAIN

The Placebo Response

(2010) Gordon Irving   CLINICAL DRUG INVESTIGATION

Gabapentin Extended-Release Tablets for the Treatment of Patients with Postherpetic Neuralgia

(2010) Mark S. Wallace et al.   CLINICAL DRUG INVESTIGATION

Pharmacokinetics of Gabapentin in a Novel Gastric-Retentive Extended-Release Formulation: Comparison With an Immediate-Release Formulation and Effect of Dose Escalation and Food

(2010) Cuiping Chen et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update

(2010) Robert H. Dworkin et al.   MAYO CLINIC PROCEEDINGS

Efficacy and Tolerability of Gastric-retentive Gabapentin for the Treatment of Postherpetic Neuralgia

(2009) Gordon Irving et al.   CLINICAL JOURNAL OF PAIN

Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive- extended-release and immediate-release tablets: A randomized, open-label, multiple-dose, three-way crossover, exploratory study in healthy subjects

(2008) Toufigh Gordi et al.   CLINICAL THERAPEUTICS

Placebo response in neuropathic pain trials☆

(2008) Steve N. Quessy et al.   PAIN

Pharmacological disruption of calcium channel trafficking by the  2  ligand gabapentin

(2008) J. Hendrich et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA